Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss and hormonal changes like PCOS could be the male equivalent of PCOS, not linked to metabolic syndrome.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Testosterone boosts physical performance, grip strength, and lean body mass in older men with low testosterone.

Balding men seen as older, less attractive, and less confident.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Finasteride can help induce ovulation and lead to a healthy birth in some women.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Testosterone reduces heart damage and inflammation after injury.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.